Evolving Strategies in Sequencing for HER2+ MBC Therapy Evolving Strategies in Sequencing for HER2+ MBC Therapy

Therapies targeting HER2+ MBC are evolving rapidly. Several recent FDA approvals offer experts an array of new options and prompt a reevaluation of treatments and sequencing strategies.Medscape Oncology
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology Article Source Type: news